Massachusetts Financial Services’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-21,524
| Closed | -$443K | – | 875 |
|
|
2016
Q3 | $443K | Buy |
21,524
+4,824
| +29% | +$99.3K | ﹤0.01% | 813 |
|
|
2016
Q2 | $511K | Sell |
16,700
-1,024
| -6% | -$31.3K | ﹤0.01% | 787 |
|
|
2016
Q1 | $663K | Sell |
17,724
-488
| -3% | -$18.3K | ﹤0.01% | 753 |
|
|
2015
Q4 | $786K | Buy |
+18,212
| New | +$786K | ﹤0.01% | 746 |
|
|
2013
Q4 | – | Sell |
-26,210
| Closed | -$616K | – | 844 |
|
|
2013
Q3 | $616K | Sell |
26,210
-960
| -4% | -$22.6K | ﹤0.01% | 773 |
|
|
2013
Q2 | $730K | Buy |
+27,170
| New | +$730K | ﹤0.01% | 750 |
|